SK pharmteco specializes in the commercial and clinical production of APIs, Advanced Intermediates, Registered Starting Materials, Key Building Blocks and Viral Vectors. Our offerings include process R&D, analytical method development and stability, scale-up and optimization, validation and commercial production. Additionally, we offer extensive Adeno-Associated Viral (AAV) and Lentiviral vector development and cGMP production capabilities.

Our global operations include 6 cGMP manufacturing and development facilities across the United States, Korea, Ireland and France. We also operate a dedicated analytical services facility.

SK pharmteco is a leader in operational excellence and continuous improvement. Our highly skilled team delivers innovative solutions utilizing advanced technologies:

• Energetic Chemistry
• Continuous Flow Processing
• Chromatography: Simulated Moving Bed (SMB) & Batch 
• High Potency (Up to 4 m3 scale & Down to 10 ng/m³ containment) 
• Controlled Substances (Schedule II-V Manufacturing)
• Particle Engineering
• cGMP Manufacturing in Adherent & Suspension Systems for Viral Vectors
• Analytical & Process Development for Viral Vectors

We provide PAI and full regulatory support as well as complete confidentiality. We have a strong record of environmental, health, and safety performance. All our plants have been successfully audited by global regulatory agencies including the FDA (US), EMA (Europe), PMDA (Japan), and MFDS (Korea). 

With a strong technology toolbox and ~1,000 m³ (~265,000 gal) of global small-molecule capacity plus a 5,000 m² facility dedicated to large molecules, we have the capability and capacity to support your needs across the full lifecycle.